BAR501 25 mg | 99.34%
TargetMol
BAR501
Search Results
BAR501 1 mg | 99.34%
TargetMol
BAR501
Acelarin 25 mg | 98.56%
TargetMol
Acelarin (NUC-1031) is a ProTide enhancement and transformation of the nucleoside analog, gemcitabine.
More Information Supplier PageAcelarin
Acelarin 2 mg | 98.56%
TargetMol
Acelarin (NUC-1031) is a ProTide enhancement and transformation of the nucleoside analog, gemcitabine.
More Information Supplier PageAcelarin
Lotamilast 25 mg | 98.44%
TargetMol
E6005 is a phosphodiesterase 4 (PDE-4) inhibitor (IC50: 2.8 nM) potentially for the treatment of atopic dermatitis.
More Information Supplier PageLotamilast
Skp2 Inhibitor C1 5 mg | Purity Not Available
TargetMol
Skp2 Inhibitor C1(SKPin C1) is a specific small molecule inhibitor of Skp2-mediated p27 degradation.
More Information Supplier PageSkp2 Inhibitor C1
Skp2 Inhibitor C1 10 mg | Purity Not Available
TargetMol
Skp2 Inhibitor C1(SKPin C1) is a specific small molecule inhibitor of Skp2-mediated p27 degradation.
More Information Supplier PageSkp2 Inhibitor C1
Skp2 Inhibitor C1 50 mg | Purity Not Available
TargetMol
Skp2 Inhibitor C1(SKPin C1) is a specific small molecule inhibitor of Skp2-mediated p27 degradation.
More Information Supplier PageSkp2 Inhibitor C1
EOC317 1 mg | 98.00%
TargetMol
EOC317 (ACTB-1003) is an oral kinase inhibitor (IC50: 6/2/4 nM, for FGFR1/VEGFR2/Tie-2).
More Information Supplier PageEOC317
Belizatinib 50 mg | 99.48%
TargetMol
Belizatinib is an effective, oral and dual inhibitor of ALK (IC50: 0.7 nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC.
More Information Supplier PageBelizatinib
